An investigator-initiated, phase II randomized, double-blind, placebo controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) Tang, J. Y., Mackay-Wiggan, J. M., Aszterbaum, M., Lindgren, J., Chang, K., Coppola, C., Campbell, A., Chanana, A., Marji, J., Callahan, C., Yauch, R., Bickers, D. R., Epstein, E. H. AMER ASSOC CANCER RESEARCH. 2011

View details for DOI 10.1158/1538-7445.AM2011-LB-1

View details for Web of Science ID 000209701302347